Traws Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Traws Pharma has a total shareholder equity of $6.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.7M and $12.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$16.89m |
Equity | US$6.10m |
Total liabilities | US$12.59m |
Total assets | US$18.69m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0T20's short term assets ($18.7M) exceed its short term liabilities ($9.9M).
Long Term Liabilities: 0T20's short term assets ($18.7M) exceed its long term liabilities ($2.7M).
Debt to Equity History and Analysis
Debt Level: 0T20 is debt free.
Reducing Debt: 0T20 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0T20 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 0T20 has less than a year of cash runway if free cash flow continues to grow at historical rates of 4.8% each year.